Mitoxantrone Hydrochloride
CAS 70476-82-3 5 FDA-DMF suppliersSmall Molecule
Overview
Mitoxantrone Hydrochloride is a synthetic antineoplastic agent used in the treatment of certain types of cancer and multiple sclerosis. It works by intercalating into DNA, disrupting replication and transcription processes.
API suppliers (1)
Suppliers of Mitoxantrone Hydrochloride backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.
- Cipla USA, Inc.USA
Therapeutic areas
OncologyMultiple Sclerosis
Ready to Accelerate Your
Discovery Workflow?
Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 14 days.